Noxopharm Ltd.'s market cap is currently AU$25.42M. The company's EPS TTM is AU$-0.012; its P/E ratio is ―; Noxopharm Ltd. is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	AU$ 2.40M	AU$ 6.01M	AU$ 5.43M	AU$ 5.61M	AU$ 8.28M
Gross Profit	AU$ -534.81K	AU$ 5.86M	AU$ 5.17M	AU$ 5.35M	AU$ 8.04M
Operating Income	AU$ -7.54M	AU$ -16.60M	AU$ -15.21M	AU$ -14.61M	AU$ -16.37M
EBITDA	AU$ -5.95M	AU$ -20.85M	AU$ -23.70M	AU$ -5.85M	AU$ -4.53M
Net Income	AU$ -3.58M	AU$ -15.06M	AU$ -18.67M	AU$ -9.35M	AU$ -272.09K
Balance Sheet
Cash & Short-Term Investments	AU$ 2.32M	AU$ 3.01M	AU$ 14.01M	AU$ 26.80M	AU$ 7.10M
Total Assets	AU$ 6.78M	AU$ 10.13M	AU$ 26.59M	AU$ 47.85M	AU$ 20.07M
Total Debt	AU$ 0.00	AU$ 0.00	AU$ 160.62K	AU$ 349.31K	AU$ 5.00M
Net Debt	AU$ -2.32M	AU$ -3.01M	AU$ -13.85M	AU$ -26.45M	AU$ -2.10M
Total Liabilities	AU$ 1.29M	AU$ 1.06M	AU$ 2.48M	AU$ 7.08M	AU$ 7.19M
Stockholders' Equity	AU$ 5.50M	AU$ 9.07M	AU$ 24.12M	AU$ 40.78M	AU$ 12.87M
Cash Flow
Free Cash Flow	AU$ -684.31K	AU$ -10.95M	AU$ -13.73M	AU$ -8.85M	AU$ -11.14M
Operating Cash Flow	AU$ -684.31K	AU$ -10.95M	AU$ -13.73M	AU$ -8.85M	AU$ -11.14M
Investing Cash Flow	AU$ 0.00	AU$ 123.51K	AU$ 0.00	AU$ 225.23K	AU$ 337.81K
Financing Cash Flow	AU$ 0.00	AU$ -178.09K	AU$ 975.73K	AU$ 28.32M	AU$ 14.99M

Currency in AUD

Noxopharm Ltd. Earnings and Revenue History

Income Statement >

Noxopharm Ltd. Debt to Assets

Balance Sheet >

Noxopharm Ltd. Cash Flow

Cash Flow >

Noxopharm Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing